Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019

Post author:Trudy Horsting
Post published:January 29, 2019
Post category:Epidermolysis Bullosa Epidermolysis bullosa simplex- Cockayne-Touraine type Epidermolysis bullosa- junctional Squamous-cell carcinoma

Epidermolysis Bullosa Epidermolysis Bullosa (EB) refers to a group of rare conditions which are characterized by fragile skin. Basically, the disease is caused by separation between the layers of the skin.…

Get Involved

Ready to get involved with Patient Worthy? Share your authentic story with others. Raise awareness and inspire change!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Get Involved

Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Get Involved

Let’s Work Together!

Keep Up to Date

Learn More